Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 12, 2009

Premium

Gary Gilliland has taken on two posts at Merck, including vice president of Merck Research Laboratories and franchise head of oncology.

Gilliland is a Harvard Medical School professor and a Howard Hughes Medical Institute investigator. He is also director for the Leukemia Program at the Dana Farber/Harvard Medical Cancer Center and director of the Cancer Stem Cell Program at the Harvard Stem Cell Institute.

He will replace Stephen Friend, who plans to leave the company to pursue an effort to build open access integrative bionetworks, or complex databases, around the world in order to accelerate disease studies.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.